|
| Search for Cases |
|
Case Details |
|
Case Code: MKTG357
|
| Case Length: 14 Pages |
| Period: 2009-2017 |
| Pub Date: 2017 |
| Teaching Note: Not Available |
| Price:Rs.500 |
| Organization : Johnson & Johnson |
Industry : Consumer Healthcare
|
| Countries : US; Europe; Global |
| Themes: Crisis Management |
| /Brand Management |
| /Marketing Ethics |
|
|
|
|
Johnson & Johnson and its Baby Powder Problem |
|
|
|
| <<Previous Page |
INTRODUCTION |
| |
| In May 2016, Johnson & Johnson (J&J) was ordered by a US jury to pay US$55 million to a woman who said that use of its talc-powder products for feminine hygiene had resulted in her developing ovarian cancer. According to her lawyers, the woman had been diagnosed with ovarian cancer and had had to undergo a hysterectomy and related surgeries. In her complaint, she accused J&J of failing for years to warn its consumers that talc, when used for feminine hygiene, was linked to an increased risk of ovarian cancer. Following a three-week trial in the Missouri state court, the plaintiff, Gloria Ristesund, was awarded US$5 million in compensatory damages and US$50 million in punitive damages. The same court had awarded a US$72 million jury award in February to the family of a woman who had died of ovarian cancer after years of using talc powder for feminine hygiene. ... |
| |
 |
| or |
 |
| or |
PayPal (11 USD)
|
|
|
| |
The verdict, which J&J planned to appeal, was the second straight trial loss for the company, which was facing about 1,200 lawsuits for its alleged failure to warn consumers about the cancer risks of its talc-based products. |
| |
| BACKGROUND NOTES - Next Page>> |
| |
|
| |
|
|
|
